跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
伽蜜芬 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Emapalumab Injection
Approved
生物制品
Emapalumab Injection
Swedish Orphan Biovitrum AB (Publ)
🇨🇳 National Medical Products Administration
Approval Date
Mar 8, 2022
Approval ID
8EflbOuintK
Company
Swedish Orphan Biovitrum AB (Publ)
Type
生物制品
Approval Details
Approval Id
8EflbOuintK
Approval Number
国药准字SJ20220010
Generic Name
依马利尤单抗注射液
Generic Name En
Emapalumab Injection
Trade Name
伽蜜芬
Drug Type
生物制品
Dosage Form
注射剂
Strength
100mg (20ml) /瓶
Reg Date
2022-03-08
Expired Date
2027-03-07
Company Name
Swedish Orphan Biovitrum AB (Publ)
Production Company Name
PATHEON ITALIA SPA
Company Detail Path
/organization/swedish-orphan-biovitrum-ab-publ
Production Company Detail Path
/organization/patheon-italia-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 8, 2022
Approval ID
8EflbOuintK
Type
生物制品
Back to NMPA Approvals